Gallagher Kathleen P. 4
4 · Avidity Biosciences, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Gallagher Kathleen P.
Chief Program Officer
Transactions
- Sale
Common Stock
2025-06-17$30.24/sh−911$27,549→ 50,392 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.